Global Injectable Anticoagulants Market Growth (Status and Outlook) 2022-2028
- LP 4876301
- 89 Pages
- February 2022
- Pharmaceuticals
The United States Injectable Anticoagulants market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Injectable Anticoagulants market, reaching US$ million by the year 2028. As for the Europe Injectable Anticoagulants landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Injectable Anticoagulants players cover Sanofi, Genentech (Roche), Boehringer Ingelheim, and Aspen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Anticoagulants market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
LMWH
Unfractionated Heparin
Fibrinolytics
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
VTE
ACS/MI
AF
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Aspen
Pfizer
Hepalink
King-friend
CSBIO
Amphastar Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injectable Anticoagulants Market Size 2017-2028
2.1.2 Injectable Anticoagulants Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Injectable Anticoagulants Segment by Type
2.2.1 LMWH
2.2.2 Unfractionated Heparin
2.2.3 Fibrinolytics
2.2.4 Others
2.3 Injectable Anticoagulants Market Size by Type
2.3.1 Injectable Anticoagulants Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Injectable Anticoagulants Market Size Market Share by Type (2017-2022)
2.4 Injectable Anticoagulants Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Others
2.5 Injectable Anticoagulants Market Size by Application
2.5.1 Injectable Anticoagulants Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Injectable Anticoagulants Market Size Market Share by Application (2017-2022)
3 Injectable Anticoagulants Market Size by Player
3.1 Injectable Anticoagulants Market Size Market Share by Players
3.1.1 Global Injectable Anticoagulants Revenue by Players (2020-2022)
3.1.2 Global Injectable Anticoagulants Revenue Market Share by Players (2020-2022)
3.2 Global Injectable Anticoagulants Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Injectable Anticoagulants by Regions
4.1 Injectable Anticoagulants Market Size by Regions (2017-2022)
4.2 Americas Injectable Anticoagulants Market Size Growth (2017-2022)
4.3 APAC Injectable Anticoagulants Market Size Growth (2017-2022)
4.4 Europe Injectable Anticoagulants Market Size Growth (2017-2022)
4.5 Middle East & Africa Injectable Anticoagulants Market Size Growth (2017-2022)
5 Americas
5.1 Americas Injectable Anticoagulants Market Size by Country (2017-2022)
5.2 Americas Injectable Anticoagulants Market Size by Type (2017-2022)
5.3 Americas Injectable Anticoagulants Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable Anticoagulants Market Size by Region (2017-2022)
6.2 APAC Injectable Anticoagulants Market Size by Type (2017-2022)
6.3 APAC Injectable Anticoagulants Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Injectable Anticoagulants by Country (2017-2022)
7.2 Europe Injectable Anticoagulants Market Size by Type (2017-2022)
7.3 Europe Injectable Anticoagulants Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Injectable Anticoagulants by Region (2017-2022)
8.2 Middle East & Africa Injectable Anticoagulants Market Size by Type (2017-2022)
8.3 Middle East & Africa Injectable Anticoagulants Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Injectable Anticoagulants Market Forecast
10.1 Global Injectable Anticoagulants Forecast by Regions (2023-2028)
10.1.1 Global Injectable Anticoagulants Forecast by Regions (2023-2028)
10.1.2 Americas Injectable Anticoagulants Forecast
10.1.3 APAC Injectable Anticoagulants Forecast
10.1.4 Europe Injectable Anticoagulants Forecast
10.1.5 Middle East & Africa Injectable Anticoagulants Forecast
10.2 Americas Injectable Anticoagulants Forecast by Country (2023-2028)
10.2.1 United States Injectable Anticoagulants Market Forecast
10.2.2 Canada Injectable Anticoagulants Market Forecast
10.2.3 Mexico Injectable Anticoagulants Market Forecast
10.2.4 Brazil Injectable Anticoagulants Market Forecast
10.3 APAC Injectable Anticoagulants Forecast by Region (2023-2028)
10.3.1 China Injectable Anticoagulants Market Forecast
10.3.2 Japan Injectable Anticoagulants Market Forecast
10.3.3 Korea Injectable Anticoagulants Market Forecast
10.3.4 Southeast Asia Injectable Anticoagulants Market Forecast
10.3.5 India Injectable Anticoagulants Market Forecast
10.3.6 Australia Injectable Anticoagulants Market Forecast
10.4 Europe Injectable Anticoagulants Forecast by Country (2023-2028)
10.4.1 Germany Injectable Anticoagulants Market Forecast
10.4.2 France Injectable Anticoagulants Market Forecast
10.4.3 UK Injectable Anticoagulants Market Forecast
10.4.4 Italy Injectable Anticoagulants Market Forecast
10.4.5 Russia Injectable Anticoagulants Market Forecast
10.5 Middle East & Africa Injectable Anticoagulants Forecast by Region (2023-2028)
10.5.1 Egypt Injectable Anticoagulants Market Forecast
10.5.2 South Africa Injectable Anticoagulants Market Forecast
10.5.3 Israel Injectable Anticoagulants Market Forecast
10.5.4 Turkey Injectable Anticoagulants Market Forecast
10.5.5 GCC Countries Injectable Anticoagulants Market Forecast
10.6 Global Injectable Anticoagulants Forecast by Type (2023-2028)
10.7 Global Injectable Anticoagulants Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Injectable Anticoagulants Product Offered
11.1.3 Sanofi Injectable Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Information
11.2.2 Genentech (Roche) Injectable Anticoagulants Product Offered
11.2.3 Genentech (Roche) Injectable Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Genentech (Roche) Main Business Overview
11.2.5 Genentech (Roche) Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Injectable Anticoagulants Product Offered
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Aspen
11.4.1 Aspen Company Information
11.4.2 Aspen Injectable Anticoagulants Product Offered
11.4.3 Aspen Injectable Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Aspen Main Business Overview
11.4.5 Aspen Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Injectable Anticoagulants Product Offered
11.5.3 Pfizer Injectable Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Hepalink
11.6.1 Hepalink Company Information
11.6.2 Hepalink Injectable Anticoagulants Product Offered
11.6.3 Hepalink Injectable Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Hepalink Main Business Overview
11.6.5 Hepalink Latest Developments
11.7 King-friend
11.7.1 King-friend Company Information
11.7.2 King-friend Injectable Anticoagulants Product Offered
11.7.3 King-friend Injectable Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 King-friend Main Business Overview
11.7.5 King-friend Latest Developments
11.8 CSBIO
11.8.1 CSBIO Company Information
11.8.2 CSBIO Injectable Anticoagulants Product Offered
11.8.3 CSBIO Injectable Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 CSBIO Main Business Overview
11.8.5 CSBIO Latest Developments
11.9 Amphastar Pharmaceuticals
11.9.1 Amphastar Pharmaceuticals Company Information
11.9.2 Amphastar Pharmaceuticals Injectable Anticoagulants Product Offered
11.9.3 Amphastar Pharmaceuticals Injectable Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Amphastar Pharmaceuticals Main Business Overview
11.9.5 Amphastar Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Injectable Anticoagulants Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of LMWH
Table 3. Major Players of Unfractionated Heparin
Table 4. Major Players of Fibrinolytics
Table 5. Major Players of Others
Table 6. Injectable Anticoagulants Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Injectable Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Injectable Anticoagulants Market Size Market Share by Type (2017-2022)
Table 9. Injectable Anticoagulants Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Injectable Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Injectable Anticoagulants Market Size Market Share by Application (2017-2022)
Table 12. Global Injectable Anticoagulants Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Injectable Anticoagulants Revenue Market Share by Player (2020-2022)
Table 14. Injectable Anticoagulants Key Players Head office and Products Offered
Table 15. Injectable Anticoagulants Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Injectable Anticoagulants Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Injectable Anticoagulants Market Size Market Share by Regions (2017-2022)
Table 20. Americas Injectable Anticoagulants Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Injectable Anticoagulants Market Size Market Share by Country (2017-2022)
Table 22. Americas Injectable Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Injectable Anticoagulants Market Size Market Share by Type (2017-2022)
Table 24. Americas Injectable Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Injectable Anticoagulants Market Size Market Share by Application (2017-2022)
Table 26. APAC Injectable Anticoagulants Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Injectable Anticoagulants Market Size Market Share by Region (2017-2022)
Table 28. APAC Injectable Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Injectable Anticoagulants Market Size Market Share by Type (2017-2022)
Table 30. APAC Injectable Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Injectable Anticoagulants Market Size Market Share by Application (2017-2022)
Table 32. Europe Injectable Anticoagulants Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Injectable Anticoagulants Market Size Market Share by Country (2017-2022)
Table 34. Europe Injectable Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Injectable Anticoagulants Market Size Market Share by Type (2017-2022)
Table 36. Europe Injectable Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Injectable Anticoagulants Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Injectable Anticoagulants Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Injectable Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Injectable Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Injectable Anticoagulants
Table 45. Key Market Challenges & Risks of Injectable Anticoagulants
Table 46. Key Industry Trends of Injectable Anticoagulants
Table 47. Global Injectable Anticoagulants Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Injectable Anticoagulants Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Injectable Anticoagulants Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Injectable Anticoagulants Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Injectable Anticoagulants Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Injectable Anticoagulants Market Size Market Share Forecast by Application (2023-2028)
Table 53. Sanofi Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors
Table 54. Sanofi Injectable Anticoagulants Product Offered
Table 55. Sanofi Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. Genentech (Roche) Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors
Table 59. Genentech (Roche) Injectable Anticoagulants Product Offered
Table 60. Genentech (Roche) Main Business
Table 61. Genentech (Roche) Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Genentech (Roche) Latest Developments
Table 63. Boehringer Ingelheim Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors
Table 64. Boehringer Ingelheim Injectable Anticoagulants Product Offered
Table 65. Boehringer Ingelheim Main Business
Table 66. Boehringer Ingelheim Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Boehringer Ingelheim Latest Developments
Table 68. Aspen Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors
Table 69. Aspen Injectable Anticoagulants Product Offered
Table 70. Aspen Main Business
Table 71. Aspen Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Aspen Latest Developments
Table 73. Pfizer Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors
Table 74. Pfizer Injectable Anticoagulants Product Offered
Table 75. Pfizer Main Business
Table 76. Pfizer Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Pfizer Latest Developments
Table 78. Hepalink Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors
Table 79. Hepalink Injectable Anticoagulants Product Offered
Table 80. Hepalink Main Business
Table 81. Hepalink Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Hepalink Latest Developments
Table 83. King-friend Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors
Table 84. King-friend Injectable Anticoagulants Product Offered
Table 85. King-friend Main Business
Table 86. King-friend Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. King-friend Latest Developments
Table 88. CSBIO Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors
Table 89. CSBIO Injectable Anticoagulants Product Offered
Table 90. CSBIO Main Business
Table 91. CSBIO Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. CSBIO Latest Developments
Table 93. Amphastar Pharmaceuticals Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors
Table 94. Amphastar Pharmaceuticals Injectable Anticoagulants Product Offered
Table 95. Amphastar Pharmaceuticals Main Business
Table 96. Amphastar Pharmaceuticals Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Amphastar Pharmaceuticals Latest Developments
List of Figures
Figure 1. Injectable Anticoagulants Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Injectable Anticoagulants Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Injectable Anticoagulants Market Size Market Share by Type in 2021
Figure 7. Injectable Anticoagulants in VTE
Figure 8. Global Injectable Anticoagulants Market: VTE (2017-2022) & ($ Millions)
Figure 9. Injectable Anticoagulants in ACS/MI
Figure 10. Global Injectable Anticoagulants Market: ACS/MI (2017-2022) & ($ Millions)
Figure 11. Injectable Anticoagulants in AF
Figure 12. Global Injectable Anticoagulants Market: AF (2017-2022) & ($ Millions)
Figure 13. Injectable Anticoagulants in Others
Figure 14. Global Injectable Anticoagulants Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Injectable Anticoagulants Market Size Market Share by Application in 2021
Figure 16. Global Injectable Anticoagulants Revenue Market Share by Player in 2021
Figure 17. Global Injectable Anticoagulants Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Injectable Anticoagulants Market Size 2017-2022 ($ Millions)
Figure 19. APAC Injectable Anticoagulants Market Size 2017-2022 ($ Millions)
Figure 20. Europe Injectable Anticoagulants Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Injectable Anticoagulants Market Size 2017-2022 ($ Millions)
Figure 22. Americas Injectable Anticoagulants Value Market Share by Country in 2021
Figure 23. Americas Injectable Anticoagulants Consumption Market Share by Type in 2021
Figure 24. Americas Injectable Anticoagulants Market Size Market Share by Application in 2021
Figure 25. United States Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Injectable Anticoagulants Market Size Market Share by Region in 2021
Figure 30. APAC Injectable Anticoagulants Market Size Market Share by Application in 2021
Figure 31. China Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Injectable Anticoagulants Market Size Market Share by Country in 2021
Figure 38. Europe Injectable Anticoagulants Market Size Market Share by Type in 2021
Figure 39. Europe Injectable Anticoagulants Market Size Market Share by Application in 2021
Figure 40. Germany Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Application in 2021
Figure 48. Egypt Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Injectable Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 54. APAC Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 55. Europe Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 57. United States Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 58. Canada Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 61. China Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 62. Japan Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 63. Korea Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 65. India Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 66. Australia Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 67. Germany Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 68. France Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 69. UK Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 70. Italy Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 71. Russia Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 72. Spain Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 75. Israel Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Injectable Anticoagulants Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
